Hostname: page-component-cb9f654ff-mx8w7 Total loading time: 0 Render date: 2025-09-05T02:41:34.371Z Has data issue: false hasContentIssue false
  • English
  • Français

Anti-Myelin Oligodendrocyte Glycoprotein Antibodies and Acute Hemorrhagic Encephalomyelitis

Published online by Cambridge University Press:  04 November 2024

Say Ying Tan ,
Presaad Pillai ,
Jack Son Wee ,
Prabha Jaya Krishna ,
Yuen Kang Chia Open the ORCID record for Yuen Kang Chia [Opens in a new window]  and
Joshua Chin Ern Ooi Open the ORCID record for Joshua Chin Ern Ooi [Opens in a new window]
Say Ying Tan
Affiliation:
Neurology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Presaad Pillai
Affiliation:
Neurology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Jack Son Wee
Affiliation:
Neurology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Prabha Jaya Krishna
Affiliation:
Radiology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Yuen Kang Chia
Affiliation:
Neurology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
Joshua Chin Ern Ooi*
Affiliation:
Neurology Department, Queen Elizabeth Hospital, Kota Kinabalu, Malaysia
*
Corresponding author: Joshua Chin Ern Ooi; Email: joshuaooichinern@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Keywords

MOGADAHEMAHLEMyelin Oligodendrocyte Glycoprotein Associated DiseaseAcute Haemorrhagic EncephalomyelitisAcute Haemorrhagic Leukoencephalitis

Information

Type
Letter to the Editor: New Observation
Information
Canadian Journal of Neurological Sciences , Volume 52 , Issue 5 , September 2025 , pp. 857 - 861
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Skarsta, L, Nicoletti, T, Frick, K et al. Acute haemorrhagic leucoencephalitis as clinical manifestation of MOG antibody-associated disease. J Neurol Neurosurg Psychiatry. 2023;94(7):583–585.CrossRefGoogle ScholarPubMed
Bang, SJ, Kim, S, Seok, HY. Acute hemorrhagic leukoencephalitis as a new phenotype of myelin oligodendrocyte glycoprotein antibody-associated disease. Neurol Sci. 2023;44(10):3741–3743.CrossRefGoogle ScholarPubMed
Grzonka, P, Scholz, MC, De Marchis, GM et al. Acute hemorrhagic leukoencephalitis: A case and systematic review of the literature. Front Neurol. 2020;11:899.CrossRefGoogle ScholarPubMed
Banwell, B, Bennett, JL, Marignier, R et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268–282.CrossRefGoogle ScholarPubMed
Forcadela, M, Rocchi, C, San Martin, D et al. Timing of MOG-IgG testing is key to 2023 MOGAD diagnostic criteria. Neurol Neuroimmunol Neuroinflam. 2024;11(1):e200183.CrossRefGoogle ScholarPubMed
Gou, B, Yang, P, Feng, J et al. The case report of AQP4 and MOG IgG double-positive NMOSD treated with subcutaneous ofatumumab. J Neuroimmunol. 2023;376:578035.CrossRefGoogle ScholarPubMed
Amin, M, Mays, M, Polston, D, Flanagan, EP, Prayson, R, Kunchok, A. Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: red flags for false positivity. J Neuroimmunol. 2021;361:577743.CrossRefGoogle Scholar
Ding, J, Li, X, Tian, Z. Clinical features of coexisting anti-NMDAR and MOG antibody-associated encephalitis: a systematic review and meta-analysis. Front Neurol. 2021;12:711376.CrossRefGoogle ScholarPubMed
Takai, Y, Misu, T, Fujihara, K, Aoki, M. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Front Neurol. 2023;14:1209749.CrossRefGoogle ScholarPubMed
McLendon, LA, Gambrah-Lyles, C, Viaene, A et al. Dramatic response to Anti-IL-6 receptor therapy in children with life-threatening myelin oligodendrocyte glycoprotein-associated disease. Neurol Neuroimmunol Neuroinflam. 2023;10(6):e200150.CrossRefGoogle ScholarPubMed